Sinovac Lands Flu Vaccine Order from Beijing CDC
October 13, 2011 at 05:25 AM EDT
Sinovac Biotech was selected by the Beijing CDC as one of the four manufacturers to supply two million doses of seasonal influenza vaccine. The actual amount shipped will depend upon demand. Sinovac needs some good news. Its sales declined from a high-water mark of $84 million in 2009, the year of the swine flu outbreak, to just $33 million in 2010. Profits fell from $20 million two years ago to a loss of $8.5 million last year. Fortunately, Sinovac has $92.7 million in cash to fall back on. More details.... Stock Symbol: (NSDQ: SVA) Share this with colleagues: